MA, V. (2010). Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes. Dove Medical Press.
Style de citation Chicago (17e éd.)MA, Via. Bromocriptine Approved as the First Medication to Target Dopamine Activity to Improve Glycemic Control in Patients with Type 2 Diabetes. Dove Medical Press, 2010.
Style de citation MLA (8e éd.)MA, Via. Bromocriptine Approved as the First Medication to Target Dopamine Activity to Improve Glycemic Control in Patients with Type 2 Diabetes. Dove Medical Press, 2010.
Attention : ces citations peuvent ne pas être correctes à 100%.